Efficacy and safety of nanoparticle albumin‑bound paclitaxel compared with solvent‑based paclitaxel in adjuvant therapy for breast cancer: A retrospective study.

Oncol Lett · 2024 · PMC11391504 · PMID 39268162

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a notable trendno p-value reported

In addition, there was a notable trend toward a lower postoperative risk of breast cancer in the nab-PTX group compared with the sb-PTX group, but no statistically significant difference was observed (HR, 0.419; 95% CI, 0.124–1.418; P=0.162).

also in 2,105 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.